HEXA and Tay-Sachs disease: Due to the mutation of the Hexa gene, patients with Tay-Sachs disease exhibit the accumulation of GM2 ganglioside in the CNS, and therefore, successful treatments should be associated with the reduction of ganglioside deposition.